ALVO (alvotech.com) Bozor qiymatining balans qiymatiga nisbati

Alvotech S.A. (ALVO) kompaniyasining rasmiy ramzlari

Alvotech (ALVO) moliyaviy barqarorligi to'lovlar tebranishlari bilan cheklangan, chunki foyda sud qarorlari va tartibga soluvchi hukmlarga bog'liq. Biroq, tijorat sotuvlarining boshlanishi kuchli naqd pul poydevorini yaratib, portfelni barqaror naqd pul generatoriga aylantirmoqda. Qiymat tendentsiyalarini aks ettiruvchi va ko'rsatkich -8.45 darajasida turgan ushbu narxlar grafigi, patent urushlari va global distribyutsiya orqali raqobatchilarni faol ravishda siqib chiqarayotgan biosimilar ishlab chiquvchining profilini to'ldiradi.

ALVO Alvotech Biopharmaceuticals: Balans qiymatiga nisbatan bozor qiymati 28.04.2023 - 27.10.2026 oraligʻida

Alvotech S.A. (ALVO) moliyaviy va bozor koʻrsatkichlari kesimi

- narx va narxlar bo'yicha konsensus prognoz:
Narx grafigi Alvotech|ALVO - Oʻrtacha prognoz narxi
- bozor kapitallashuvi bo'yicha ma'lumotlar:
Bozor qiymati Alvotech Corp|ALVO - Biznesning to‘liq qiymati
- balans kapitallashuvi bo'yicha ma'lumotlar:
Bitta aksiya hisobiga balans qiymati Alvotech|ALVO - Kompaniyaning buxgalteriya qiymati|Bozor kapitallashuvining balans qiymatiga nisbati alvotech.com|ALVO - Kompaniyaning umumiy aktivlari
- qarz va likvidlik bo'yicha ma'lumotlar:
Qarzning xususiy kapitalga nisbati Alvotech|ALVO - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Qisqa muddatli qarzning o'z kapitaliga nisbati Alvotech Corp|ALVO - Kompaniyaning umumiy qarzi|Balans kapitallashuviga qarzlar Alvotech Corp
Kompaniyaning dastlabki tahlili:Alvotech - ALVO
Alvotech Corp original mahsuloti

Ushbu ko'rsatkich bozor narxining kompaniya sof aktivlariga nisbatini o'lchash orqali fundamental biznes qiymatini spekulyativ shovqinlardan ajratadi. Alvotech (ALVO) uchun, uning modeli chuqur R&D va sog'liqni saqlash gigantlari bilan strategik ittifoqlarga asoslangan holda, kitob qiymatiga nisbatan narx koeffitsienti intellektual mulk va ishlab chiqarish quvvatlarining haqiqiy qiymatiga nisbatan haddan tashqari yuqori baholangan kotirovkalarning aniq detektori vazifasini o'taydi.

Asosiy raqobatchilar

Bozor qiymatining balans qiymatiga nisbati HLN|KVUE (kenvue.com) - Bozor qiymatining balans qiymatiga koeffitsiyenti|Bozor qiymatining balans qiymatiga nisbati Verona Pharma VRNA|Sof aktivlarga nisbatan bozor kapitallashuvi Jyong Biotech Limited|Ligand Pharma (LGND) - Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati Amneal Corp (AMRX)|Bozor kapitallashuvining balans qiymatiga nisbati PRGO (Perrigo Company plc)|liquidia.com - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati Galapagos (GLPG)|ANIP: Balans qiymatiga nisbatan bozor qiymati|MNKD (MannKind Corp.) - Bozor qiymatining balans qiymatiga nisbati|Amphastar Corp (AMPH) - Kapitallashuvning sof aktivlarga nisbati|PCRX (Pacira BioSciences) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati ars-pharma.com (SPRY)|Theravance Biopharma, Inc. (TBPH) - Kapitallashuvning sof aktivlarga nisbati|Balans qiymatiga nisbatan bozor qiymati AQST (Aquestive Therapeutics Inc)|SCPH: Bozor qiymatining balans qiymatiga nisbati|TECX - Bozor qiymatining balans qiymatiga koeffitsiyenti|Kapitallashuvning sof aktivlarga nisbati Tonix Pharmaceuticals TNXP|SXTC - Bozor kapitallashuvining balans qiymatiga multiplikatori|Bozor kapitallashuvining balans qiymatiga nisbati eupraxiapharma.com EPRX|BioHarvest Sciences, Inc. (BHST) - Balans qiymatiga nisbatan bozor qiymati|Bozor kapitallashuvining balans qiymatiga nisbati EXOZ (Invizyne Technologies, Inc.)|Bozor qiymatining balans qiymatiga koeffitsiyenti ORMP|Entera Bio Ltd. (ENTX) - Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati ipatherapeutics.com (HYFT)|Bozor kapitallashuvining balans qiymatiga nisbati ABVC (ABVC BioPharma, Inc.)|Cumberland Pharmaceuticals Inc - Bozor kapitallashuvining balans qiymatiga nisbati|QNTM - Bozor qiymatining balans qiymatiga nisbati|FibroGen Corporation (FGEN) - Bozor qiymatining balans qiymatiga nisbati|Telomir Pharmaceuticals (TELO) - Kapitallashuvning sof aktivlarga nisbati|RANI (Rani Therapeutics Holdings, Inc.) - Bozor qiymatining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati SNYR (Synergy CHC Corp.)|Bozor qiymatining balans qiymatiga koeffitsiyenti Rallybio Corp. (RLYB)|Kapitallashuvning sof aktivlarga nisbati Lexaria Bioscience|Bozor kapitallashuvining balans qiymatiga multiplikatori Pulmatrix Corporation (PULM)|PTHL: Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti Aptorum Group Ltd APM|LYRA: Bozor kapitallashuvining balans qiymatiga nisbati|IBO - Kapitallashuvning sof aktivlarga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati tnfpharma.com TNFA|cbdMD (YCBD) - Balans qiymatiga nisbatan bozor qiymati|PRFX (PainReform Ltd.) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati CYTO|Bozor qiymatining balans qiymatiga nisbati Lipella Pharmaceuticals, Inc. (LIPO)|Bozor qiymatining balans qiymatiga nisbati OptiNose Inc OPTN|Kapitallashuvning sof aktivlarga nisbati Pieris PIRS|Procaps Group Corp - Bozor qiymatining balans qiymatiga nisbati|PTPI (Petros Pharmaceuticals) - Bozor qiymatining balans qiymatiga nisbati|QLI: Bozor qiymatining balans qiymatiga koeffitsiyenti|Bozor qiymatining balans qiymatiga nisbati ACELYRIN (SLRN)|TFF Pharmaceuticals Inc. (TFFP) - Sof aktivlarga nisbatan bozor kapitallashuvi